Literature DB >> 9076655

A survey of the values of clinical chemistry parameters obtained for a common rat blood sample in ninety-eight Japanese laboratories.

T Matsuzawa1, Y Hayashi, M Nomura, T Unno, T Igarashi, T Furuya, K Sekita, A Ono, Y Kurokawa, Y Hayashi.   

Abstract

A control survey was conducted to check the accuracy of automated analyzers used in the evaluation of clinical chemistry parameters in nonclinical toxicology studies. Pooled serum samples from male Sprague-Dawley rats were delivered refrigerated to each facility 98 laboratory facilities throughout Japan within 18 hours after sample preparation and analyzed. Commercially available normal human serum samples from a single lot were also analyzed at the same time. Survey results were divided into three categories. (1) Parameters with small coefficient of variation (CV) values for both rat and human serum samples included protein, glucose, cholesterol (CHO), urea nitrogen (UN), sodium (Na), potassium (K), chloride (Cl), calcium (Ca), and inorganic phosphate (IP). Definition of normal values in rats should be straight forward for these parameters. (2) Parameters with large CV values, but with a relatively good correlation between rat and human values include triglycerides (TG), glutamic oxaloacetic transaminase/aspartate aminotransferase (GOT/AST), glutamic pyruvic transaminase/alanine aminotransferase (GPT/ALT), and alkaline phosphatase (ALP). Measurements based on different principles gave different mean values, and this values contributed to the increase in CV values. Assessment of normal values would require a consideration of the measurement principles. (3) Parameters with large CV values only in rat serum samples included albumin (albumin/globulin ratio: A/G ratio), creatinine (CRE), and total bilirubin(BIL). Reactivity was different in rat albumin (ALB), depending on the reagents used. This difference needs to be corrected with values available by electrophoresis, or adjusted by rat ALB values, because of the lack of an appropriate measurement method. The enzyme method gave low values for rat CRE, which suggests the need for further examination of this method. The BIL values were extremely low in rat samples. It seems to be necessary to select appropriate methods to measure clinical pathology parameters correctly for rats. There was no deviation in values due solely to the mechanical operations of the analytical equipment. Non-standard initial settings of the equipment (equipment originally intended for human samples, but now applied to animal samples) was the main cause of the wide range of analytical values seen.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9076655     DOI: 10.2131/jts.22.25

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  4 in total

1.  Clinical biochemistry parameters in C57BL/6J mice after blood collection from the submandibular vein and retroorbital plexus.

Authors:  Itziar Fernández; Arantza Peña; Nahia Del Teso; Virginia Pérez; Juan Rodríguez-Cuesta
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-03       Impact factor: 1.232

2.  Nopal feeding reduces adiposity, intestinal inflammation and shifts the cecal microbiota and metabolism in high-fat fed rats.

Authors:  Sofia Moran-Ramos; Xuan He; Elizabeth L Chin; Armando R Tovar; Nimbe Torres; Carolyn M Slupsky; Helen E Raybould
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

3.  Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice.

Authors:  Sandra Medina-Moreno; Thomas C Dowling; Juan C Zapata; Nhut M Le; Edward Sausville; Joseph Bryant; Robert R Redfield; Alonso Heredia
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

4.  Safety evaluation of a bioglass-polylactic acid composite scaffold seeded with progenitor cells in a rat skull critical-size bone defect.

Authors:  Karam Eldesoqi; Dirk Henrich; Abeer M El-Kady; Mahmoud S Arbid; Bothaina M Abd El-Hady; Ingo Marzi; Caroline Seebach
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.